Report overview
Antipyretic Analgesic Agent are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report contains market size and forecasts of Antipyretic Analgesic Anti-Inflammatory Drugs in global, including the following market information:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Antipyretic Analgesic Anti-Inflammatory Drugs companies in 2022 (%)
The global Antipyretic Analgesic Anti-Inflammatory Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Paracetamol Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antipyretic Analgesic Anti-Inflammatory Drugs include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antipyretic Analgesic Anti-Inflammatory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Type, 2022 (%)
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues share in global market, 2022 (%)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
